From 21Oct to 23Oct 2020, Effepharm will attend Asiaceutical Summit & Expo 2020 in Guangdong, China. As an exhibitor, our booth will be B17. At the expo, Effepharm will introduce its next-generation NMN – Uthever® to our customers and the public. At 14:00, 22Oct2020, our Director of Scientific and Regulatory Affairs will be addressing a […]Read more
- What are the changes NMN can visibly make on you?
- NMN Has Anti-Aging Potential for Kidneys
- How does NMN work in Sirtfood Diet?
- Meet us at CPhi 2020 at E5A08
- UTHEVER®NMN awarded 2020 Top 10 Hot raw materials in the nutrition and health industry
Researchers from Keio University and Washington University published a new article on Endocrine Journal. The safety of single dose at 100, 250, and 500 mg NMN was investigated in 10 Japanese men. Clinical findings and parameters, and the pharmacokinetics of NMN metabolites were investigated for 5 h after each intervention. The study concluded that the single oral administration […]Read more
Effepharm started our new clinical trials on UtheverTM NMN ingredient recently. According to ICTRP ( International Clinical Trials Registry Platform), the clinical trial on UtheverTM is the largest scale trial on NMN in the world. What’s more, Effepham is the first and the only NMN ingredient manufacturer to conduct clinical trials in the world. And we will stand […]Read more
Effepharm acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has significantly enhanced our R&D capability in anti-aging and energy metabolism. Also Effepharm’s new R&D center is established. Effepharm’s new R&D center will focus on new pharmaceutical and dietary ingredient development by means of plant extraction, fermentation and synthesis, etc. It is expected […]Read more
From 2nd to 4th Oct 2019, Effepharm team participated in Hi Japan Exhibit, the Largest Trade Show for Functional & Health Ingredients in Japan. Effepharm is in line with the purpose of this event. Its Highlights: not only the food industry but also cosmetics, pharmaceuticals and proposal of development of high added value food with appealing […]Read more
On 7th May, 2019, Sales team at Effepharm came to vitafoods with latest products and new technology. Booth Position：Sliver Area No. N189 NMN- Popular NAD+ Precursors CBD- This ingredient is very popular in many Europe countries. Effepharm’s R&D has scheduled to devote more efforts into this ingredient development. That would be one outbreaking ingredient in […]Read more
Effepharm Ltd. currently not only holds a strong R&D team consisting of experienced PHDs and Postdocs returned from abroad, but also employs senior professors and scholars at home and abroad as a team of research consultants to help us optimize production applications. Effepharm owns HPLC, GC, infrared, ultraviolet and other conventional testing equipment, and signs […]Read more
May. 2019, Effepharm teams will participate in Vitafoods Europe 2019 Exhibit, a annual event where the global nutraceutical supply chain come to gether to do business At that time, Effepharm teams will be waiting for your inquiry and cooperation in booth of Sliver Area No. N189. Effepharm’s booth location diagram is as follows. EffePharm […]Read more
“Once-in-two-lifetimes Ingredients”–NMN or NR? Nowadays, the people all over the world spend billions of dollars on anti-aging products. While most anti-aging products try to reverse signs of aging on your skin, Nicotinamide Rboside aims to reverse signs of aging from inside your body. However, most human studies are short in duration and have very few participants. For a more accurate […]Read more
Sales Office transferred to Shanghai The sales office was transferred to Shanghai in 2017-EffePharm(Shanghai)Co.,Ltd At Effepharm, we apply science and technologies to improve health and well-being at every stage of life with innovative thinking. Our dedicated team strive to set the standard for quality, safety and value in the discovery, development and manufacturing of health […]Read more